Elevance Health, Inc. — Director's Dealing 2021

Nov 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2021-11-01

Reporting Person: Haytaian Peter D (EVP & Pres., DBG & IngenioRx)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-01	Common Stock	A	1167	—	Acquired	22711	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-01	Employee Stock Option (Right to Buy)	$428.76	A	4786	Acquired	2031-11-01	Common Stock (4786.0)	Direct

Footnotes

F1: Represents restricted share units. Restrictions lapse as follows: 389 shares each on 11/1/2022, 11/1/2023 and 11/1/2024.

F2: The option represents a right to purchase a total of 4,786 shares, and is exercisable in three annual installments, with two installments of 1,595 shares each and one installment of 1,596 shares, beginning on 11/01/2022, which is the one-year anniversary of the option grant date.